vs

Side-by-side financial comparison of AMERICAN WOODMARK CORP (AMWD) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

AMERICAN WOODMARK CORP is the larger business by last-quarter revenue ($394.6M vs $217.5M, roughly 1.8× Tilray Brands, Inc.). AMERICAN WOODMARK CORP runs the higher net margin — 1.5% vs -20.7%, a 22.2% gap on every dollar of revenue. On growth, Tilray Brands, Inc. posted the faster year-over-year revenue change (3.1% vs -12.8%). Over the past eight quarters, Tilray Brands, Inc.'s revenue compounded faster (7.5% CAGR vs -3.3%).

American Woodmark Corporation is a kitchen and bath cabinet manufacturer headquartered in Winchester, Virginia. The company operates several manufacturing facilities and service centers. The manufacturing facilities are located in Arizona, Georgia, Indiana, Kentucky, Maryland, Tennessee, Virginia, and West Virginia with service centers being located throughout the country.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

AMWD vs TLRY — Head-to-Head

Bigger by revenue
AMWD
AMWD
1.8× larger
AMWD
$394.6M
$217.5M
TLRY
Growing faster (revenue YoY)
TLRY
TLRY
+15.9% gap
TLRY
3.1%
-12.8%
AMWD
Higher net margin
AMWD
AMWD
22.2% more per $
AMWD
1.5%
-20.7%
TLRY
Faster 2-yr revenue CAGR
TLRY
TLRY
Annualised
TLRY
7.5%
-3.3%
AMWD

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
AMWD
AMWD
TLRY
TLRY
Revenue
$394.6M
$217.5M
Net Profit
$6.1M
$-44.9M
Gross Margin
15.2%
26.4%
Operating Margin
3.1%
-10.2%
Net Margin
1.5%
-20.7%
Revenue YoY
-12.8%
3.1%
Net Profit YoY
-78.0%
47.4%
EPS (diluted)
$0.42
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMWD
AMWD
TLRY
TLRY
Q4 25
$394.6M
$217.5M
Q3 25
$403.0M
$209.5M
Q2 25
$400.4M
$224.5M
Q1 25
$397.6M
$185.8M
Q4 24
$452.5M
$210.9M
Q3 24
$459.1M
$200.0M
Q2 24
$453.3M
$229.9M
Q1 24
$422.1M
$188.3M
Net Profit
AMWD
AMWD
TLRY
TLRY
Q4 25
$6.1M
$-44.9M
Q3 25
$14.6M
$-322.0K
Q2 25
$25.6M
$-1.3B
Q1 25
$16.6M
$-789.4M
Q4 24
$27.7M
$-85.3M
Q3 24
$29.6M
$-39.2M
Q2 24
$26.8M
$-31.7M
Q1 24
$21.2M
$-92.7M
Gross Margin
AMWD
AMWD
TLRY
TLRY
Q4 25
15.2%
26.4%
Q3 25
16.7%
27.4%
Q2 25
17.0%
30.1%
Q1 25
15.0%
28.0%
Q4 24
18.9%
29.0%
Q3 24
20.2%
29.8%
Q2 24
18.6%
35.8%
Q1 24
19.2%
26.2%
Operating Margin
AMWD
AMWD
TLRY
TLRY
Q4 25
3.1%
-10.2%
Q3 25
5.0%
1.0%
Q2 25
7.4%
-643.1%
Q1 25
5.3%
-409.0%
Q4 24
9.4%
-20.0%
Q3 24
10.2%
-18.3%
Q2 24
8.4%
-7.2%
Q1 24
6.6%
-43.6%
Net Margin
AMWD
AMWD
TLRY
TLRY
Q4 25
1.5%
-20.7%
Q3 25
3.6%
-0.2%
Q2 25
6.4%
-566.9%
Q1 25
4.2%
-424.9%
Q4 24
6.1%
-40.5%
Q3 24
6.5%
-19.6%
Q2 24
5.9%
-13.8%
Q1 24
5.0%
-49.2%
EPS (diluted)
AMWD
AMWD
TLRY
TLRY
Q4 25
$0.42
$-0.41
Q3 25
$1.00
$0.00
Q2 25
$1.73
$7.26
Q1 25
$1.09
$-8.69
Q4 24
$1.79
$-0.99
Q3 24
$1.89
$-0.04
Q2 24
$1.70
$-0.04
Q1 24
$1.32
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMWD
AMWD
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$52.1M
$291.6M
Total DebtLower is stronger
$363.3M
Stockholders' EquityBook value
$928.2M
$1.6B
Total Assets
$1.6B
$2.1B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMWD
AMWD
TLRY
TLRY
Q4 25
$52.1M
$291.6M
Q3 25
$54.9M
$264.8M
Q2 25
$48.2M
$256.4M
Q1 25
$43.5M
Q4 24
$56.7M
$252.2M
Q3 24
$89.3M
$280.1M
Q2 24
$87.4M
$260.5M
Q1 24
$97.8M
$225.9M
Total Debt
AMWD
AMWD
TLRY
TLRY
Q4 25
$363.3M
Q3 25
$364.8M
Q2 25
$365.8M
Q1 25
$367.3M
Q4 24
$368.0M
Q3 24
$372.2M
Q2 24
$371.8M
Q1 24
$371.3M
Stockholders' Equity
AMWD
AMWD
TLRY
TLRY
Q4 25
$928.2M
$1.6B
Q3 25
$920.3M
$1.5B
Q2 25
$916.0M
$1.5B
Q1 25
$919.6M
$2.7B
Q4 24
$915.1M
$3.5B
Q3 24
$913.8M
$3.5B
Q2 24
$910.4M
$3.4B
Q1 24
$896.9M
$3.4B
Total Assets
AMWD
AMWD
TLRY
TLRY
Q4 25
$1.6B
$2.1B
Q3 25
$1.6B
$2.1B
Q2 25
$1.6B
$2.1B
Q1 25
$1.6B
Q4 24
$1.6B
$4.2B
Q3 24
$1.6B
$4.3B
Q2 24
$1.6B
$4.2B
Q1 24
$1.6B
$4.2B
Debt / Equity
AMWD
AMWD
TLRY
TLRY
Q4 25
0.39×
Q3 25
0.40×
Q2 25
0.40×
Q1 25
0.40×
Q4 24
0.40×
Q3 24
0.41×
Q2 24
0.41×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMWD
AMWD
TLRY
TLRY
Operating Cash FlowLast quarter
$11.2M
$-8.5M
Free Cash FlowOCF − Capex
$638.0K
FCF MarginFCF / Revenue
0.2%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$64.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMWD
AMWD
TLRY
TLRY
Q4 25
$11.2M
$-8.5M
Q3 25
$33.1M
$-1.3M
Q2 25
$44.8M
$-12.8M
Q1 25
$11.0M
$-5.8M
Q4 24
$11.9M
$-40.7M
Q3 24
$40.8M
$-35.3M
Q2 24
$43.3M
$30.7M
Q1 24
$43.7M
$-15.4M
Free Cash Flow
AMWD
AMWD
TLRY
TLRY
Q4 25
$638.0K
Q3 25
$25.3M
Q2 25
$35.8M
$-19.1M
Q1 25
$2.3M
$-20.2M
Q4 24
$1.1M
$-46.2M
Q3 24
$29.5M
$-42.0M
Q2 24
$7.2M
$21.0M
Q1 24
$22.1M
$-24.9M
FCF Margin
AMWD
AMWD
TLRY
TLRY
Q4 25
0.2%
Q3 25
6.3%
Q2 25
8.9%
-8.5%
Q1 25
0.6%
-10.9%
Q4 24
0.2%
-21.9%
Q3 24
6.4%
-21.0%
Q2 24
1.6%
9.1%
Q1 24
5.2%
-13.2%
Capex Intensity
AMWD
AMWD
TLRY
TLRY
Q4 25
2.7%
Q3 25
1.9%
Q2 25
2.2%
2.8%
Q1 25
2.2%
7.8%
Q4 24
2.4%
2.6%
Q3 24
2.5%
3.4%
Q2 24
8.0%
4.2%
Q1 24
5.1%
5.1%
Cash Conversion
AMWD
AMWD
TLRY
TLRY
Q4 25
1.83×
Q3 25
2.27×
Q2 25
1.75×
Q1 25
0.66×
Q4 24
0.43×
Q3 24
1.38×
Q2 24
1.62×
Q1 24
2.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMWD
AMWD

Home Center Retailers$166.7M42%
Builders$164.7M42%
Independent Dealersand Distributors$63.2M16%

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons